In this episode of your ONCOmmunity podcast, we will debate the importance of networking and the increasing role of molecular tumour boards.
OnkoMedeor is a group of eight oncological day clinics which diagnose and treat tumour diseases as outpatient services. OnkoMedeor is part of a very strong network, where oncologists, surgeons, radiologists, pathologists and molecular pathologists regularly meet and take part in tumour boards.
Prof. Dr. Dirk Hempel, managing director, and Dr. Kristina Riedmann, leader of the molecular tumour boards of the Group, discuss the importance of networking.
“For oncologists in private practice and for routine care, it will be extremely important to organize a cross-sector network for the implementation of molecular diagnostics and molecular tumour boards. These (molecular tumour boards) are increasingly being offered virtually, so that precision oncology will find its way into broad, nationwide patient care and ultimately all patients, whether they live in the countryside or in the city, can benefit from such diagnostics and therapy.”